Carbamazepine is an anticonvulsant with mood-stabilizing properties. Equetro® (extended-release carbamazepine) has been approved by the FDA for the treatment of bipolar I disorder. Here is basic information about this medication.
Mood stabilizer for the treatment of acute manic or mixed episodes associated with bipolar I disorder
Initial: 200 mg twice daily
Titrate: 200 mg/day until clinical response
Maximum: 1600 mg/day
1. Reduce dose gradually when discontinuing treatment.
2. Monitor serum carbamazepine concentrations to help in dose selection and minimizing the risk of toxicity.
3. Capsules may be taken orally or opened and beads sprinkled over food.
Dosage forms and strengths
Extended-release capsules (Equetro® and generic): 100 mg, 200 mg, and 300 mg
Extended-release tablets (Tegretol®-XR and generic): 100 mg, 200 mg, and 400 mg
Please refer to Prescribing Information (see link below) for complete discussion of dosage, administration, warnings and precautions, contraindications, etc.
Copyright 2016, Rajnish Mago, MD. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons, or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.